Trade TRAX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
First Tracks Biotherapeutics, Inc. (TRAX) is trading at US$41.64, down 6.34% today as of Nov 20, 16:00 EST. The company has a market capitalisation of US$1.58B. Over the past 52 weeks, TRAX has traded between US$14.72 and US$54.78. On Syfe you can trade TRAX with $0 commission and add it to your watchlist.
| Previous close | US$44.46 |
|---|---|
| Market cap | US$1.58B |
| 52-week range | US$14.72 – US$54.78 |
| Volume | 501.58K |
| Exchange | US |
First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.
Year: 2026
First Tracks Biotherapeutics Announces $200 Million Private Placement
Oct 15, 12:52 PM · MT Newswires
Sector Update: Healthcare Stocks Advance in Afternoon Trading
Oct 12, 5:41 PM · MT Newswires
Sector Update: Healthcare Stocks Higher Pre-Bell Monday
Oct 12, 1:20 PM · MT Newswires
First Tracks Biotherapeutics Says ANB033 Reduces Gluten-Induced Intestinal Damage in Celiac Disease
Oct 12, 12:03 PM · MT Newswires
Canaccord Genuity Initiates First Tracks Biotherapeutics at Buy With $50 Price Target
Sep 30, 9:55 AM · MT Newswires
First Tracks Biotherapeutics, Inc. (TRAX) stock is trading at US$41.64, -6.34% from the previous close of US$44.46.
The market cap for First Tracks Biotherapeutics, Inc. (TRAX) stock is approximately US$1.58B.
The 52-week high for First Tracks Biotherapeutics, Inc. (TRAX) stock is US$54.78.
The 52-week low for First Tracks Biotherapeutics, Inc. (TRAX) stock is US$14.72.
First Tracks Biotherapeutics, Inc. (TRAX) does not currently pay a dividend.
Stay on top of TRAX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore